Reliable guiding for efficient laboratory automation equipment
Cytokines are the basis of communication between immune system cells and normal cells. The novel coronavirus pneumonia (COVID-19), which began to rage around the world in 2020, is a significant cause of death in critically ill patients. The so-called "cytokine storm" causes acute respiratory distress and multiple organ failure. The use of cytokine monitoring equipment and treatment can substantially improve efficiency and reduce the number of deaths.
Lower Total Cost of Ownership (TCO)
“At the same time as our analysers,
we also developed a total of 70 in vitro diagnostic kits,
covering all routine clinical tests
and each with unique detection abilities.”
Mr Xu Jiongkuan – Lihe Biotech R&D Manager
Why does Lihe Biotech trust Ewellix’s miniature linear guides in their equipment?
Lihe Biotech developed a detection kit that can give advanced diagnostic abilities for patients with severe infections. During this time, they also created an immunoassay analyser (H360) kit, which needed to produce 360 test results per hour.
“The severity of the epidemic required us to develop more efficient and reliable detection equipment, which also requires higher performance for vital mechanical components." Said Mr Xu.
Ewellix provides high-performance miniature guides with their LLS series for the new generation of automatic chemiluminescence immunoassay analysers needed by Suzhou Lihe. The LLS series comes in a wide range of sizes (7-15 mm) and can support various linear motion guidance functions such as probing and sampling. Its most outstanding features are its low friction resistance, 20,000 km travel without lubrication or maintenance, and strong corrosion resistance.
"The lower friction resistance of Ewellix's LLS guides makes it unnecessary for us to increase the size of the motor in the equipment, thereby lowering overall costs. Our equipment remains the industry leader in the market and effectively saves on waiting time for patients and at the same time, avoids after-sales costs caused by rail guide corrosion." States Mr Xu.
Lihe Biotech attaches great importance to the planning and investment of R & D, improving the overall core competitiveness of the company through the development and improvement of quality products.
About Lihe Biotech
Lihe Biotech , the 'promoter of intelligent medical laboratory platforms', are committed to producing first-class domestic immune/biochemical testing systems and assembly line platforms that provide reliable and cost-effective products and services for the medical testing industry. They are enabling patients, testing institutions and manufacturers to share the fruits of scientific and technological progress. To enhance the competitiveness of domestic products and improve the influence of national brands in the long-term, in line with the vision of Suzhou Lihe.